For: | Li YJ, Ji XR. Relationship between expression of E-cadherin-catenin complex and clinicopathologic characteristics of pancreatic cancer. World J Gastroenterol 2003; 9(2): 368-372 [PMID: 12532469 DOI: 10.3748/wjg.v9.i2.368] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i2/368.htm |
Number | Citing Articles |
1 |
Anouchka Skoudy, Inmaculada Hernández-Muñoz, Pilar Navarro. Pancreatic Ductal Adenocarcinoma and Transcription Factors: Role of c-Myc. Journal of Gastrointestinal Cancer 2011; 42(2): 76 doi: 10.1007/s12029-011-9258-0
|
2 |
E A Rakha, D Abd El Rehim, S E Pinder, S A Lewis, I O Ellis. E‐cadherin expression in invasive non‐lobular carcinoma of the breast and its prognostic significance. Histopathology 2005; 46(6): 685 doi: 10.1111/j.1365-2559.2005.02156.x
|
3 |
Nicoletta Gagliano, Tatiana Volpari, Marco Clerici, Letizia Pettinari, Isabella Barajon, Nicola Portinaro, Graziano Colombo, Aldo Milzani, Isabella Dalle-Donne, Carla Martinelli. Pancreatic cancer cells retain the epithelial-related phenotype and modify mitotic spindle microtubules after the administration of ukrain in vitro. Anti-Cancer Drugs 2012; 23(9): 935 doi: 10.1097/CAD.0b013e32835507bc
|
4 |
Pengbo Wang, Zengkuan Zhu. Prognostic and Clinicopathological Significance of E-Cadherin in Pancreatic Cancer Patients: A Meta-Analysis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.627116
|
5 |
R. Sedivy, K. Peters, G. Kl�ppel. Osteopontin expression in ductal adenocarcinomas and undifferentiated carcinomas of the pancreas. Virchows Archiv 2005; 446(1): 41 doi: 10.1007/s00428-004-1142-x
|
6 |
A. Gasiorowska, R. Talar-Wojnarowska, A. Kaczka, A. Borkowska, L. Czupryniak, E. Małecka-Panas. Subclinical Inflammation and Endothelial Dysfunction in Patients with Chronic Pancreatitis and Newly Diagnosed Pancreatic Cancer. Digestive Diseases and Sciences 2016; 61(4): 1121 doi: 10.1007/s10620-015-3972-6
|
7 |
Niki A. Ottenhof, Roeland F. de Wilde, Anirban Maitra, Ralph H. Hruban, G. Johan A. Offerhaus. Molecular Characteristics of Pancreatic Ductal Adenocarcinoma. Pathology Research International 2011; 2011: 1 doi: 10.4061/2011/620601
|
8 |
Francesca Bianchi, Michele Sommariva, Laura Brigida Cornaghi, Luca Denti, Ambra Nava, Francesca Arnaboldi, Claudia Moscheni, Nicoletta Gagliano. Mechanical Cues, E-Cadherin Expression and Cell “Sociality” Are Crucial Crossroads in Determining Pancreatic Ductal Adenocarcinoma Cells Behavior. Cells 2022; 11(8): 1318 doi: 10.3390/cells11081318
|
9 |
Seung Geun Lee, Jeoung Won Bae, Jong Han Kim, Yang Suk Chae, Kyu Ran Cho, Jae Bok Lee, Gil Soo Son, Bum Hwan Koo. Biologic Behavior of E-cadherin in Invasive Ductal Carcinoma of the Breast. Journal of Breast Cancer 2006; 9(2): 105 doi: 10.4048/jbc.2006.9.2.105
|
10 |
Ning Li, Xiaobing Chen, Xiangbin Wan, Suxia Luo, Lili Han, Mengqiang Zhou, Dengwen Yin, Li Zhang. Relationship between expression of CEA, E-cadherin and liver metastasis in colorectal cancer. Chinese Journal of Clinical Oncology 2008; 5(6): 429 doi: 10.1007/s11805-008-0429-0
|
11 |
Tommaso Mazza, Massimiliano Copetti, Daniele Capocefalo, Caterina Fusilli, Tommaso Biagini, Massimo Carella, Antonio De Bonis, Nicola Mastrodonato, Ada Piepoli, Valerio Pazienza, Evaristo Maiello, Fabio Francesco di Mola, Pierluigi di Sebastiano, Angelo Andriulli, Francesca Tavano. MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater's papilla adenocarcinoma. Oncotarget 2017; 8(62): 105320 doi: 10.18632/oncotarget.22184
|
12 |
Michele Sommariva, Nicoletta Gagliano. E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT. Cells 2020; 9(4): 1040 doi: 10.3390/cells9041040
|
13 |
Matthias M. Gaida, Thomas Große Steffen, Frank Günther, Darjus F. Tschaharganeh, Klaus Felix, Frank Bergmann, Peter Schirmacher, Gertrud M. Hänsch. Polymorphonuclear neutrophils promote dyshesion of tumor cells and elastase‐mediated degradation of E‐cadherin in pancreatic tumors. European Journal of Immunology 2012; 42(12): 3369 doi: 10.1002/eji.201242628
|
14 |
Adam Elzagheid, Annika Ålgars, Riyad Bendardaf, Hanan Lamlum, Raija Ristamaki, Yrjo Collan, Kari Syrjanen, Seppo Pyrhonen. E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome. World Journal of Gastroenterology 2006; 12(27): 4304-4309 doi: 10.3748/wjg.v12.i27.4304
|
15 |
M. Hebrok. Gastroenterology Yesterday — Today — Tomorrow: A Review and Preview. Falk Symposium 2005; 144: 234 doi: 10.1007/1-4020-2916-0_22
|
16 |
Nurkan Torer, Fazilet Kayaselcuk, Tarik Zafer Nursal, Sedat Yildirim, Akin Tarim, Turgut Noyan, Hamdi KarakayalI. Adhesion molecules as prognostic markers in pancreatic adenocarcinoma. Journal of Surgical Oncology 2007; 96(5): 419 doi: 10.1002/jso.20654
|
17 |
Lydie Crescence, Evelyne Beraud, Veronique Sbarra, Jean-Paul Bernard, Dominique Lombardo, Eric Mas. Targeting a Novel Onco-glycoprotein Antigen at Tumoral Pancreatic Cell Surface by mAb16D10 Induces Cell Death. The Journal of Immunology 2012; 189(7): 3386 doi: 10.4049/jimmunol.1102647
|
18 |
Gabriella Canavese, Amelia Bernardi, Gianluigi Candelaresi, Patrizia Lovadina, Simonetta Amerio, Veronica Rossetti, Claudio Rabagliati, Ester Berardengo. Expression of the E-cadherin–catenins complex in sentinel node is related to tumor morphology but not to spread to nonsentinel nodes. Pathology - Research and Practice 2007; 203(7): 517 doi: 10.1016/j.prp.2007.03.003
|
19 |
Alena Bashinskaya, Jay Kammerman, David Butson, Patricia Moody. Metastatic Pancreatic Acinar Cell Carcinoma: An Unlikely Culprit. Cureus 2023; doi: 10.7759/cureus.38288
|
20 |
Seung-Mo Hong, Ang Li, Kelly Olino, Christopher L Wolfgang, Joseph M Herman, Richard D Schulick, Christine Iacobuzio-Donahue, Ralph H Hruban, Michael Goggins. Loss of E-cadherin expression and outcome among patients with resectable pancreatic adenocarcinomas. Modern Pathology 2011; 24(9): 1237 doi: 10.1038/modpathol.2011.74
|
21 |
Margherita Sisto, Domenico Ribatti, Sabrina Lisi. Cadherin Signaling in Cancer and Autoimmune Diseases. International Journal of Molecular Sciences 2021; 22(24): 13358 doi: 10.3390/ijms222413358
|
22 |
H. Doucas, G. Garcea, C.P. Neal, M.M. Manson, D.P. Berry. Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance. European Journal of Cancer 2005; 41(3): 365 doi: 10.1016/j.ejca.2004.11.005
|
23 |
Said Khayyata, Olca Basturk, Nazmi V Adsay. Invasive micropapillary carcinomas of the ampullo-pancreatobiliary region and their association with tumor-infiltrating neutrophils. Modern Pathology 2005; 18(11): 1504 doi: 10.1038/modpathol.3800460
|
24 |
Yu-Jun Li, Zhi-Min Wei, Yun-Xiao Meng, Xiang-Rui Ji. β-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: Relationships with carcinogenesis and metastasis. World Journal of Gastroenterology 2005; 11(14): 2117-2123 doi: 10.3748/wjg.v11.i14.2117
|
25 |
Sunil Chada, Dora Bocangel, Abujiang Pataer, Abner M. Mhashilkar, Satoshi Inoue, Ryo Miyahara, Jack A. Roth, Elizabeth A. Grimm, Stephen G. Swisher, Kelly K. Hunt, Rajagopal Ramesh. Gene Therapy for Cancer. Cancer Drug Discovery and Development 2007; : 413 doi: 10.1007/978-1-59745-222-9_23
|
26 |
Virginie Audard, Catherine Cavard, Hubert Richa, Muriel Infante, Anne Couvelard, Alain Sauvanet, Benoît Terris, François Paye, Jean-François Flejou. Impaired E-Cadherin Expression and Glutamine Synthetase Overexpression in Solid Pseudopapillary Neoplasm of the Pancreas. Pancreas 2008; 36(1): 80 doi: 10.1097/mpa.0b013e318137a9da
|
27 |
Adriana Handra-Luca, Pascal Hammel, Alain Sauvanet, Claude Lesty, Philippe Ruszniewski, Anne Couvelard. EGFR expression in pancreatic adenocarcinoma. Relationship to tumour morphology and cell adhesion proteins. Journal of Clinical Pathology 2014; 67(4): 295 doi: 10.1136/jclinpath-2013-201662
|
28 |
Jun-Ming Guo, Bing-Xiu Xiao, De-Jian Dai, Qiong Liu, Hong-Hui Ma. Effects of daidzein on estrogen-receptor-positive and negative pancreatic cancer cells <i>in vitro</i>. World Journal of Gastroenterology 2004; 10(6): 860-863 doi: 10.3748/wjg.v10.i6.860
|
29 |
Hai-Dan Wang, Jun Ren, Lian Zhang. CDH1 germline mutation in hereditary gastric carcinoma. World Journal of Gastroenterology 2004; 10(21): 3088-3093 doi: 10.3748/wjg.v10.i21.3088
|
30 |
Javier Martinez-Useros, Jesus Garcia-Foncillas. Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/4873089
|
31 |
Lorenza González-Mariscal, Jael Miranda, Helios Gallego-Gutiérrez, Misael Cano-Cortina, Elida Amaya. Relationship between apical junction proteins, gene expression and cancer. Biochimica et Biophysica Acta (BBA) - Biomembranes 2020; 1862(9): 183278 doi: 10.1016/j.bbamem.2020.183278
|
32 |
Wenjun Gu, Wei Liu, Xizhong Shen, Yuan Shi, Lei Wang, Hailin Liu. Emergence of heterogeneous nuclear ribonucleoprotein A2/B1 vs loss of E-cadherin: their reciprocal immunoexpression profiles in human pancreatic cancer. Annals of Diagnostic Pathology 2013; 17(1): 14 doi: 10.1016/j.anndiagpath.2012.04.004
|
33 |
Yin-Cheng He, Wei Peng, Jian-Guo Qiao, Jun Cao, Ji-Wei Chen. Relationship between nuclear morphometry, DNA content and resectability of pancreatic cancer. World Journal of Gastroenterology 2003; 9(8): 1863-1865 doi: 10.3748/wjg.v9.i8.1863
|